RAS P21 EXPRESSION IN RELATION TO HISTOPATHOLOGICAL VARIABLES AND PROGNOSIS IN COLORECTAL ADENOCARCINOMA

被引:11
|
作者
SUN, XF
HATSCHEK, T
WINGREN, S
STAL, O
CARSTENSEN, JM
ZHANG, H
BOERYD, B
SJODAHL, R
NORDENSKJOLD, B
机构
[1] LINKOPING UNIV HOSP,DEPT PATHOL,S-58185 LINKOPING,SWEDEN
[2] LINKOPING UNIV HOSP,DEPT SURG,S-58185 LINKOPING,SWEDEN
关键词
RAS P21; HISTOPATHOLOGY; PROGNOSIS; COLORECTAL ADENOCARCINOMA; IMMUNOHISTOCHEMISTRY;
D O I
10.3109/02841869109088246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ras gene protein products (p21) reacting with the monoclonal antibodies ras 11, DWP, R256 and E184 were studied with an immunohistochemical method which was applied to 17 normal and 79 colorectal adenocarcinoma specimens. Normal colorectal epithelium showed positive staining for ras 11 in 35% of the cases, but not for DWP, R256 and E184. The antibodies showed positive staining in colorectal adenocarcinomas in 76, 53, 29 and 35% of the cases respectively. The degree of staining for ras 11 was significantly related to the grade of differentiation and increased from Dukes stage A to C. Strong staining for ras 11 predicted a significantly shorter recurrence-free interval (p < 0.001). In Cox's regression analysis, the degree of staining for ras 11 was a prognostic factor independent of the grade of differentiation and Dukes stage (p < 0.01). The results indicate that the enhanced expression of pan ras p21 may provide an important biological marker for determining prognosis in colorectal adenocarcinomas.
引用
收藏
页码:933 / 939
页数:7
相关论文
共 50 条
  • [31] Expression of ras p21 in the stromal cells of human neoplastic endometrium
    Miturski, R
    Semczuk, A
    Jakowicki, JA
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (03) : 308 - 311
  • [32] EXPRESSION OF RAS P21 ONCOPROTEIN IN NORMAL AND NEOPLASTIC HUMAN ENDOMETRIUM
    SCAMBIA, G
    CATOZZI, L
    BENEDETTIPANICI, P
    FERRANDINA, G
    BATTAGLIA, F
    GIOVANNINI, G
    DISTEFANO, M
    PELLIZZOLA, D
    PIFFANELLI, A
    MANCUSO, S
    GYNECOLOGIC ONCOLOGY, 1993, 50 (03) : 339 - 346
  • [33] ANTISENSE INHIBITION OF RAS P21 EXPRESSION THAT CONTAINS A POINT MUTATION
    CHANG, EH
    MILLER, P
    DEVADAS, K
    TSO, P
    YU, ZP
    CLINICAL CHEMISTRY, 1992, 38 (03) : 454 - 455
  • [34] EXPRESSION OF P21 RAS IN NORMAL AND PATHOLOGICAL BREAST-TISSUE
    GOING, JJ
    ANDERSON, TJ
    WYLLIE, AH
    JOURNAL OF PATHOLOGY, 1988, 155 (04): : A347 - A347
  • [35] RAS P21 EXPRESSION IN NEPHRO-BLASTOMA GROUP TUMORS
    AOKI, I
    YANOMA, S
    MISUGI, K
    SASAKI, Y
    KIKYO, S
    ACTA PATHOLOGICA JAPONICA, 1987, 37 (12): : 1903 - 1907
  • [36] ANTISENSE INHIBITION OF RAS P21 EXPRESSION THAT IS SENSITIVE TO A POINT MUTATION
    CHANG, EH
    MILLER, PS
    CUSHMAN, C
    DEVADAS, K
    PIROLLO, KF
    TSO, POP
    YU, ZP
    BIOCHEMISTRY, 1991, 30 (34) : 8283 - 8286
  • [37] QUANTITATIVE EXPRESSION OF RAS P21 IN THE URINE OF PATIENTS WITH UROLOGIC CANCERS
    MACFARLANE, MT
    BROSMAN, SA
    JACOBS, MA
    LIU, BCS
    JOURNAL OF UROLOGY, 1987, 137 (04): : A147 - A147
  • [38] Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma
    Lee, CS
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (03): : 233 - 237
  • [39] Expression of p53, p16, p21, P21ras, and P27 in Patients Exhibiting Gastric Adenocarcinoma With Submucosa Invasion
    Moron, Roberson A.
    Cecconello, Ivan
    Jacob, Carlos E.
    Gama-Rodrigues, Joaquim
    Alves, Venancio A.
    Zilberstein, Bruno
    Simoes, Kleber
    Iryia, Kiyoshi
    GASTROENTEROLOGY, 2010, 138 (05) : S733 - S733
  • [40] AN IMMUNOHISTOCHEMICAL STUDY OF HUMAN RAS GENE-PRODUCT P21 EXPRESSION IN ADENOCARCINOMA ARISING IN BARRETT-ESOPHAGUS
    SAMOWITZ, W
    THOR, A
    SMITH, RRL
    HAMILTON, SR
    LABORATORY INVESTIGATION, 1986, 54 (01) : A56 - A56